Vol.
96, No.
1, 1980
September
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
Pages 341-349
16, 1980
PROTON NMR STUDY OF IRON(BLEOMYCIN: ASSIGNMENT OF RESONANCES BY SATURATION TRANSFER EXPERIMENTS Rajasekharan J. Michael
P. Pillai, Robert E. Lenkinski, Ted T. Sakai, Geckle, N. Rama Krishna and Jerry D. Glickson*
Physical Biochemistry and Pharmacology Program of the Comprehensive Cancer Center and Department of Biochemistry, University of Alabama in Birmingham, Birmingham, AL 35294
Received
June 7,198O
Summary The assignment bleomycin complex method. A number which are shifted complex in H20. with the formation Curie Law or the the valeric acid N=, the carbamoyl may be coordinated
of the paramagnetically shifted in D 0 has been accomplished using of a 2ditional resonances arising by the metal ion are observed in The temperature dependence of the of an isolated 1:l complex, but Curie-Weiss Law. The magnitude of hydroxyl (or carbonyl) group, the oxygen, the pyrimidine Nl and/or to the iron(I1).
The bleomycins with
DNA, their
metal
ions
drug
cause nucleic
with
suggest
putative
(1,2).
bleomycins of free
In the presence strand bases
acids serves
Oppenheimer
(7-8)
target,
of molecular
and with
(12)
The Fe(I1)
have
various
recently
complex complex
oxygen
for
metals
reported
and a diamagnetic exhibited
(17)
in making
1 Abbreviations:
B-amino alanine; THR: threonine;
the assignments
of the resonances
polyvalent
and iron(
the
complexes metal
release of the
ions
to nucleic
(9-14)
acids,
(15,16). 1 a H NMR study
while
of a
Bleo-A2-Fe(II)-CO
paramagnetically
both to low field and to high field of the spectrum In the present study, we report the use of saturation
complexes
various
polyvalent binds
form
the concommitant
of the binary
end of the molecule site
which
and with
of DNA with
Studies
as a chelation
--et al. Bleo-A2-Fe(II)l
in D20.
antibiotics
scission
(3-6).
the C-terminal
the N-terminus paramagnetic
1) are antitumor pharmacological
single acid
nucleic that
complex
(Fig.
resonances of the Fe(II)the transfer of saturation fromllabile NE protons the H spectrum of the chemical shifts is consistent does not obey either the the shifts suggests that a-amino group, the imidazole the secondary amino group
shifted
resonances
of the metal-free antibiotic. transfer experiments
of the paramagnetic
Fe(II)-
Bleo-A2: Bleomycin-A2; TSP: Trimethylsilyl propionate; PYR: Pyrimidinyl propionamide; HIS: B-hydroxyhistidine; G: Gulose; M: Mannose; VAL: valerate.
341
ALA:
0006-291X/80/170341-09$01.00/0 Copyright 0 1980 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol.
96, No.
BIOCHEMICAL
1. 1980
AND
BIOPHYSICAL
RESEARCH
COMMUNlCATlONS
+ BLEOYYCIW
A2 :
R= -N”(W~3S(C*$2
62
R=
H
:
-N”(W&+~-N’$
B-HYDROXYHISTIDIBE
Figure Bleo-A2
On the basis
complex.
hydrogens ligation
in close
proximity
structure
of these
of bleomycin
assignments
to the metal
congeners.
we are
and to suggest
able
to identify
a set
of probable
sites.
We have ermination
previously
demonstrates
employed
of the kinetics
of the bleomycin of exchange
antibiotics
of the peptide the
feasibility
tion
and dissociation
this
method
Materials
Primary
1
NY+
are
available
saturation
transfer
of dissociation (18,19) NE's
of the
as well
of peptide
of a similar
as in
Zn(I1) (20).
complexes
of the kinetics
The present
of the kinetics
complex.
in the literature
in the det-
and Ga(III)
the analysis
hormones analysis
of the Fe(II)-Bleo-A2
experiments
Detailed
study
of formatreatments
of
(17,20-22).
and Methods
Sample Preparation. Bleomycin-A2 chloride was purified from Blenoxane (Bristol Laboratories, Syracuse, NY), the commercial mixture of bleomycin congeners, by chromatography on carboxymethyl Sephadex C-25 (23). Due to the extreme sensitivity of Fe(II)-bleomycin to oxidation, all samples were prepared under strict oxygen-free conditions. Bleomycin-A2 (20.5 pmoles) lyophilized from D2Q was dissolved in 0.500 ml of ultrapure D2Q (99.96% D, One half equivalent of a solution Merck, Sharp and Dohme, Montreal, Canada).
'Iron(IIji) complexes of bleomycin have been found to be in fast exchange on the H NMR chemical shift time scale. In contrast with the Fe(I1) system, the Fe(III) complex exhibits relatively small shifts, but substantial broadening of the bithiazole resonances.
342
Vol.
96, No.
BIOCHEMICAL
1, 1980
50
40
30
AND
BIOPHYSICAL
20
lo
RESEARCH
0
COMMUNICATIONS
-IO
-20
8 wm
Figure
2
The 400 MH& 'H NMR spectrum of Fe(II)-Bleo-A2 in ;60=";.t3;; K; Bleo-A2 = 38.5 mM; Fe(II) = 19.3 mu; The assignments of the shifted peaks are also shown. Inset: Representative difference
spectrum from the transfer of saturation experiment at 303'K. The tail of the arrow represents the peak that is saturated and the head indicates the resonance to which magnetization is transferred. The HOD signal at 4.8 ppm is caused by signal "breakthrough." of FeSO 4. 7H 0 in D20 was added to this solution and the pH (the meter reading uncorrected z or the deuterium isotope effect) was adjusted to 6.30 with NaOD. The sample was transferred to a purged 5 mm NMR tube, which was immediately sealed. The absence of significant oxidation of Fe(II) to Te(III) was ascertained The Fe(II)from the characteristics of the NMR spectrum of the sample. bleomycin-A2 sample in H20 was prepared by an analogous procedure. NMR Spectra. Proton NMR spectra were obtained at 400 MHz on a Bruker All chemical shifts were calculated with respect NH-400 NMR spectrometer. For the transfer of saturation experiments, TSP as the internal standard. the shifted resonances were selectively saturated using gated homonuclear decoupling with a decoupling time of 2-3 set and ca. 15 db below .l watt in H20 was obtained using The spectrum of Fe(II)-bleomycin-A2attenuation. Redfield 2-1-4-1-2 sequence (24). Results NMR Spectrum in D20 is
shown
in D20. in Figure
The 'H NMR spectrum 2.
The spectrum
343
of the Fe(II)-Bleo-A2
is a superposition
complex
of the res-
to
a
Vol.
96, No.
BIOCHEMICAL
1, 1980
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
b. 9
7
8
*** * IL JL
a. 0
9
L 2
7
6
6 Figure
3
of free
Bleo-A 2, which
(9-O ppm) and those
between
50 and -20
of the metal diamagnetic at 13.1
as shown the
spectrum resonance
r
0
3
to the normal
in Figure
also
and the
contains
inset
at 13.1
cluster
The assignment
saturation
in the
complex
complex,
transfer of Figure
ppm results
complex
were
the previously
made in an analogous of the free unassigned
drug
manner
(11,12,25) sugar
extend
a few resonances
using
resonances
344
which
occur
at
shifted A typical
Saturation
of the 3
transfer
of saturation
resonance resonances
of Valerie of the
the known
and our recent
of resonances of the
experiments. 2. in
(% 10%) to 1.13 ppm, which corresponds to the u-methyl acid of free bleomycin. The assignments of the other resonances
spectral
which
3. All the resonances outside the of a single proton, except the resonance
to 3 protons using
diamagnetic
iron
region
of 5 or 6 protons.
is shown
of the
limited
intensity
corresponds
consists
was accomplished
difference
are
of the paramagnetic The diamagnetic
have
ppm which
resonances
ppm.
complex region
Q -1 ppm which
proton
4
The diamagnetic region of the 400 MHz 1H NMK spectrum of Fe(II)-Bleo-A . (a) pH = 6.30, T = 303'K; (b) pH = 8.0, T 1 ',%%O* Asterisks (*) indicate resonances that belong to the complex.
onances range
8, ;pm
assignments
assignments between
of the of some of
3.5 and 4.1
ppm
Vol.
96, No.
(e.g.
:
1. 1980
BIOCHEMICAL
M-4 at 3.88
G-3 at 4.12 experiment
rature
were
diamagnetic
is
(15).
Curie
transfer
do not obey
Weiss
shown in Figure measured
metal
in
ion. are
Bleo-A2
Experiments
complicated
with
in
by
by extrathose
obtained
the chemical to l/T)
shifts or the
of Fe(II)-Bleo-A2
still
yet
bleomycin
which
in progress
including These
interact
to identify
relaxation
in H20 (25),
observed,
observed).
NH protons
by the shorter
in H 0 is 2 in the spectrum
observed
are
resonance from
are
agree
of free
by asterisks)
in H20 originate
as reported
is
+ constant)).
2 and 3) and those
field
to the
behavior
obtained
Law (A6 proportional
to the resonances
(indicated
lowest
only
l/(T
This
The changes
Curie
vs tempe-
to extrapolate
complex
do not
of the
shifts
shifts
The 'H NMR spectrum
in D20 (Figures
observed
temperature
In addition
of resonances
67 ppm (the
but
4.
1:l
the diamagnetic
simple
in H2g.
ppm and
of saturation
dependence
temperature.
experiments.
Law (A6 linear
NMR Spectrum
number
the
transfer
and appear
of an isolated
However, to infinite
saturation
of the
of the chemical
298OK and 333OK,
the formation
of the plot
(A&) also
Plots
(9 to 0 ppm) at infinite
with
COMMUNlfATlONS
ppm, M-2 at 4.06
The temperature
I.
region et al.
the
of Shifts. in Table
between
Sausville from
shown
RESEARCH
I.
linear
consistent polation
The results
in Table
Dependence
shifts
BIOPHYSICAL
ppm, G-2 at 4.04
pH = 6.3).
summarized
Temperature chemical
ppm, G-4 at 3.91
ppm at 303'K, are
AND
times
resonances
with these
of these
a
one at the paramagnetic
resonances,
protons.
Discussion The quantitative would
require
dipolar are
interpretation
estimates
mechanisms
to each of
not available,
present
data.
shifts
originate
shifts,
useful It
since
reviews
qualitative
likely
do not
numerous
of the
the paramagnetic
that
Although
information
in close
shifts
proximity
imply
very
remoteness
from
the magnitude
of paramagnetic
shifts
have
the
paramagnetic ion.
the metal
of the shifts. appeared
and
estimates from
large
to the metal
identified
contact
these
can be obtained
exhibiting
can diminish
herein
of the Fermi
shifts.
resonances
necessarily
effects
analysis
contributions
the observed
from hydrogens
however,
site
is
of
of the relative
in the
Small binding Detailed literature
(26-28). It
can be seen from
sulfonium
group
in agreement C-terminus NTI.
It
observed
is
with
previous
C4EJ is noteworthy
either
I that
and the bithiazole
of bleomycin
the imidazole
Table
protons
studies in metal
consistent that
by saturation
the shifts
which
are all
a shifted transfer
relatively
indicate
minimal
(9-11).
The large
binding with
exhibited
the metal
coordination
imidazole
C2g resonance
experiments
345
by the dimethylsmall.
This
involvement shift
of the exhibited
of the has not
or by comparing
is by
imidazole been the spectrum
Vol.
96, No.
1, 1980
BIOCHEMICAL
II
AND
9
IO
BIOPHYSICAL
RESEARCH
8
COMMUNICATIONS
7
6
I
30
r-7 70
Figure
with
4
that
The close 3
Bleo-A2
25
65
60
20
55
50 6, pm
Ii
45
40
IO
35
30
The 400 MH; 'H NMR spectrum of Fe(II)-Bleo-A in FjiOEa;.;;; K, Bleo-A2 = 46.3 mM, Fe(II) = 237.2 XVM, Asterisks (*) indicate shifted NH - resonances. of a sample proximity
in which of the
in D20 was heated
the imidazole
imidazole for
C2-H is
replaced
C21J to NT could
readily
12 hours
at 85'C.
346
by deuterium. shift
its
3
resonance
Vol.
96, No.
1, 1980
BIOCHEMICAL
Summary of Saturation Saturated
AND
Transfer
Peak
BlOPHYSlCAL
Table I Experiments
RESEARCH
COMMUNICATIONS
at 303'K and pH = 6.3
Saturation Transfer observed at ~-
Assignment'
d6/dT
l/2
-0.26 -0.23 -0.41 -0.22 -0.16
45.2 ppm+ 42.7 39.6 32.9+ 24.7 20.3
2.83
3.98
VAl.
13.1
1.21
VAL Cag3 BITHIAZOLE C H 5BITHIAZOLE C5'lJ VAL C'H3 THR C"! DIMETHYLSULFONIUM Cfi3 M-l
7.38
2.55 3.80
1.13 4.22
2.8
2.94
a.12 7.83
5.01 of peaks)
Peaks ranging 3.8
-5.1 -6.6 -11.6
from
-0.12
-0.12
Sugar ClJ's, ALA or PYR CH M-2 (or ALA Call) ALA C"fl (or G-2) G-l (HIS Call or CBH) M-4 M-3
4.80
t Temperature
C'H-
ppm
3.89
-15.1+
+p, = 8.0,
- 4.1
4.13 4.10 5.37
-3.9
C4bJ
VAL CaH l/2 PYR CE2 VAL CBH -
2.58
7.9 + 7.7 i 7.1 6.5 9 0.6 + -1 ppm (cluster
PYR Cg2 HIS
0.05 0.07 0.07 0.10
0.10
= 323'K Temperature
= 313'K
5The uncertainty in the assignment of some of these resonances arises out of the complexity of the spectrum of the free drug between 3.8 and 4.1 ppm where several Cg resonances overlap. out of the observed observed
for
carbamoyl this
several
group
equivalent
spectral
shifts
range
resonances
or broaden
of the mannose
may be coordinated of the
it
beyond residue
to the metal
two distinct
pyrimidine
ion.
The shifts
detection. indicate The very
Cg2 resonances
that large
the and non-
suggest
that
group
may be adjacent to the metal ion binding site due to ligation of The perturbation of the CH the secondary amine. Nl and/or These the a-amino group as a ligand. of the alanine moiety implicates
the pyrimidine proton results
are
complexes
compatible in the
The shifts the valeric
acid
literature exhibited residue
with
the
results
of other
studies
of metal-bleomycin
(9-13). by the Cull, suggest
that
C$,
C'Ij,
this
residue
347
CaI13 and CylS3 resonances may also
be ligated
of to the
Vol.
96, No.
metal
the valeric
acid
the
imidazole
data
tends
analogue
ligation
site
to favor group
The above Fe(I1)
the
cc-amino
such a complex. premature
group,
structure
with
Zn(I1)
shifts (which
of this
the hydroxyl
of might
residue
of the metal
However,
to formulate
the following
imidazole
over
ion.
group
to construct
Our
or the
are now in progress of iron(bleomycin
model
in
this
for
valeric space
data,
the structure
laboratory
to further its
acid
magnetic
for
with it
of this
the
filling
structures
associated
experimental
and to determine
for
With
of plausible
as other
sites
oxygen,
group.
the uncertainties
as well
any detailed
amino
a number
of
coordination
Nn, carbamoyl
the secondary
in view
of the present
Experiments
with
to placement
explanation
COMMUNICATIONS
the anomalous
coordination
suggest
Nl and/or
we have been able
interpretation
RESEARCH
as the ligand.
considerations
complex:
of Fe(II))
or to direct
latter
serving
OH or CO, pyrimidine models,
BIOPHYSICAL
--et al. (11) have attributed resonances of the Bleo-A2 complex
as a diamagnetic
carbonyl
AND
Oppenheimer
ion.
serve
BIOCHEMICAL
1, 1980
the is
complex.
define
the
and kinetic
properties. Acknowledgement We thank the generous Service (TTS)
Grants
Drs. gift
W.T.
Bradner
of Blenoxane.
CA-13148
and by a Faculty
and S.T. This
(John
R. Durant
Research
Award
Crooke
research
of Bristol was supported
and JDG), FRA-162
Laboratories
CA-24411
(JDG) from
by Public (JDG),
for Health
GM-27900
the American
Cancer
Society. REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.
Umezawa, H. (1973) Biomedicine 18, 459-475. Crooke, S.T. and Bradner, W.T. (1976) J. Med. 7, 333-428. Lown, J.W. and Sim, S.K. (1977) Biochem. Biophys. Res. Commun. 77, 1150-1157. Ishida, R. and Takahashi, T. (1975) Biochem. Biophys. Res. Commun. 66, 1432-1438. Miiller, W.E.G., Yamazaki, Z.I., Breter, H.J. and Zahn, R.K. (1972) Eur. J. Biochem. 31,518-525. Haidle, C.W. (1971) Molec. Pharmacol. 7, 645-652. Chien, M., Grollman, A.P. and Horwitz, S.B. (1977) Biochemistry 16, 3641-3647. Chen, D-M., Sakai, T.T., Glickson, J.D. and Patel, D.J. (1980) Biochem. Biophys. Res. Commun. 92, 197-205. Dabrowiak, J.C., Greenway, F.T., Longo, W.E., Van Husen, M. and Crooke, S.T.,(1978) Biochim. Biophys. Acta, 517, 517-526. Dabrowiak, J.C., Greenway, F.T. and Grulich, R. (1978) Biochemistry 17, 4090-4096. Oppenheimer, N.J., Rodriguez, L.O. and Hecht, S.M. (1979) Biochemistry 16, 3439-3445. Oppenheimer, N.J., Rodriguez, L.O. and Hecht, S.M. (1979) Proc. Natl. Acad. Sci. USA, 76, 5616-5620. Iitaka, Y.,Nakamura, H., Nakatani,T., Muraoka,Y., Fujii, A., Takita, T. and Umezawa, H. (1978) J. Antibiotics 31, 1070-1072. Cass, A.E.G., Goldes, A., Hill, A.O. and McClelland, C.C. (1978) FEBS Lett. 89, 187-190.
348
Vol.
15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28.
96, No.
1. 1980
BIOCHEMICAL
AND
BlOPHYSlCAL
RESEARCH
COMMUNICATIONS
Sausville, E.A., Peisach, J. and Horwitz, S.B. (1976) Biochem. Biophys. Res. commun. 73, 814-821. Sausville, E.A., Stein, R.W., Peisach, .I. and Horwitz, S.B. (1978) Biochemistry 17, 2746-2753. Gupta, R.K. and Redfield, A.G. (1970) Biochem. Biophys. Res. Commun. 41, 273-281. Lenkinski, R.E. and Dallas, J.L. (1979) J. Amer. Chem. Sot. 101, 5902-5906. Lenkinski, R.E., Peerce, B-E., Dallas, J.L. and Glickson, J.D. (1980) J. Amer. Chem. Sot. 102, 131-135. Krishna, N.R., Huang, D.H., Glickson, J.D., Rowan, R. III and Walter, R. (1979) Biophys. J. 26, 345-366. in NMR Spectroscopy, Vol. 1, Hoffman, R.A. and Forsen, S. (1966) in Progress ed. Emsley, Feeney and Sutcliffe (pergamon Press, New York) pp. 15-204. Krishna, N.R., Huang, D.H. and Goldstein, G. (1980) Applied Spectroscopy, 34, 460-464. Fujii, A., Takita, T., Maeda, K. and Umezawa, H. (1973) J. Antibiotics 26, 396-397. Redfield, A.G. (1978) Methods Enzymol. 49, 253-270. Chen, D.M., Hawkins, B.L. and Glickson, J.D. (1977) Biochemistry 16, 2731-2738. Wiithrich, K. (1976) NMR in Biological Research (American Elsevier, New York) Chapter 6, pp. 221-286. J.P. (1973) in NMR of Paramagnetic Molecules, ed. La Mar, Horrocks Jesson, and Holm (Academic Press, New York) pp. l-52. Resonance Eaton, D.R. and Phillips, W.D. (1965) in Advances in Magnetic ed. J.S. Waugh Academic Press, New York) pp. 103-148.
349